1. Home
  2. ACTU vs RELL Comparison

ACTU vs RELL Comparison

Compare ACTU & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • RELL
  • Stock Information
  • Founded
  • ACTU 2015
  • RELL 1947
  • Country
  • ACTU United States
  • RELL United States
  • Employees
  • ACTU N/A
  • RELL N/A
  • Industry
  • ACTU
  • RELL Electronic Components
  • Sector
  • ACTU
  • RELL Technology
  • Exchange
  • ACTU NYSE
  • RELL Nasdaq
  • Market Cap
  • ACTU 135.0M
  • RELL 127.4M
  • IPO Year
  • ACTU 2024
  • RELL N/A
  • Fundamental
  • Price
  • ACTU $10.35
  • RELL $8.89
  • Analyst Decision
  • ACTU Strong Buy
  • RELL
  • Analyst Count
  • ACTU 1
  • RELL 0
  • Target Price
  • ACTU $20.00
  • RELL N/A
  • AVG Volume (30 Days)
  • ACTU 71.1K
  • RELL 73.2K
  • Earning Date
  • ACTU 05-21-2025
  • RELL 04-09-2025
  • Dividend Yield
  • ACTU N/A
  • RELL 2.71%
  • EPS Growth
  • ACTU N/A
  • RELL N/A
  • EPS
  • ACTU N/A
  • RELL N/A
  • Revenue
  • ACTU N/A
  • RELL $204,394,000.00
  • Revenue This Year
  • ACTU N/A
  • RELL $9.48
  • Revenue Next Year
  • ACTU N/A
  • RELL $4.10
  • P/E Ratio
  • ACTU N/A
  • RELL N/A
  • Revenue Growth
  • ACTU N/A
  • RELL N/A
  • 52 Week Low
  • ACTU $5.51
  • RELL $7.57
  • 52 Week High
  • ACTU $11.73
  • RELL $15.51
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • RELL 42.06
  • Support Level
  • ACTU N/A
  • RELL $8.67
  • Resistance Level
  • ACTU N/A
  • RELL $9.06
  • Average True Range (ATR)
  • ACTU 0.00
  • RELL 0.32
  • MACD
  • ACTU 0.00
  • RELL 0.17
  • Stochastic Oscillator
  • ACTU 0.00
  • RELL 72.00

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.

Share on Social Networks: